Intermediates

Product

Homepage

Intermediates

(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

(1S,2S,3R,5S)-(+)-2,3-Pinanediol

(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

(R)-(+)-1-(1-Naphthyl)ethanol

(R)-(+)-1-(1-Naphthyl)ethylamine

(R)-(+)-1-Phenylethanol

【Alias】L-Phenylethanol; (R)-(+)-1-Phenylyl alcohol; R-(+)-sec-phenylethanol
【Catalog Number】CR8011
【CAS #】1517-69-7
【Molecular Formula】 C8H10O
【Molecular Weight】122.16

(R)-(3-Chlorophenyl)oxirane

(R)-(4-Fluorophenyl)oxirane

(R)-1-(4-Bromophenyl)ethanol

(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride

(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one

(R)-2-(1-Hydroxyethyl)pyridine

(R)-2-(4-Chlorophenyl)oxirane

(R)-4-(1-Hydroxyethyl)pyridine

(S)-(-)-1-(1-Naphthyl)ethanol

(S)-(-)-1-Phenylethanol

【Alias】D-1-phenylethanol; (S)-(-)-1-phenylethanol
【Catalog Number】CR8010
【CAS #】1445-91-6
【Molecular Formula】C8H10O
【Molecular Weight】122.16

(S)-(-)-Styrene Oxide

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile

(S)-1-(4-Bromophenyl)ethanol

News Center

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA 2024-12-04 15:57:06

Recently, Viwit Pharmaceuticals received the "Drug registration certificate" issued by China National Medical Products Administration (NMPA) for Brimonidine Tartrate and Timolol Maleate Eye Drops. The approval number is H20249650. This signifies that the product has received official approval for the Chinese market and has successfully passed the generic drug consistency evaluation.

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA 2024-10-22 14:48:28

Recently, Viwit Pharmaceuticals' proprietary developed Nitroglycerin Sublingual Tablets (strengths: 0.3 mg, 0.4 mg, 0.6 mg) received a marketing authorization letter from the US Food and Drug Administration (US FDA), ANDA number: 218583, signifying the product's official approval in the US market.

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated" 2024-09-23 14:46:43

From July 15 to 19, 2024, FDA inspectors conducted a five-day on-site cGMP (Current Good Manufacturing Practice) inspection of Viwit Pharmaceuticals Co., Ltd. (referred to as Viwit API manufacturing facility). Recently, the FDA's official website showed that Viwit's API manufacturing facility successfully passed the cGMP on-site audit with a perfect result of NAI, meaning "Zero 483". This is the second time Viwit's API manufacturing facility has successfully passed the U.S. FDA audit, further affirming Viwit’s robust and continuous production management and quality systems.

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US. 2024-09-18 09:00:00

Viwit Pharmaceuticals (Viwit), an innovation driven biopharmaceutical and healthcare company has entered into an exclusive licensing and supply agreement with Zydus Lifesciences Ltd.’s wholly owned subsidiary, Zydus Lifesciences Global FZE for Gadobutrol Injection (generic version of GADAVIST) and Gadoterate Meglumine Injection (generic version of DOTAREM) for the US market.

Viwit Pharmaceutical’s Lifitegrast API has completed registrations in both China and the US! 2024-08-14 11:55:51

Recently, Viwit Pharmaceutical’s self-developed Lifitegrast API has completed the registrations in China and the United States. The API registration number is Y20240000726, and the US DMF number is 040172.

Viwit Pharmaceutical's Varenicline Tartrate Tablet receives official approval from South Africa 2024-07-15 10:01:41

Recently, theViwit independently developed smoking cessation drug Varenicline (Tartrate) Tablets, in strengths of 0.5 mg and 1 mg, received the Drug Registration Certificate issued by the South African Health Products Regulatory Authority (SAHPRA).

Intermediates

Categories:Intermediates
Time of issue:2020-03-11 00:00:00
Views:0

Description:

Information

Sr. No.	Chemical Name	CAS No.	Molecular Formula	Structure
1	Pyridine-2-sulfonyl Fluoride	878376-35-3	C₅H₄FNO₂S
2	(S)-(-)-1-Phenylethanol	1445-91-6	C₈H₁₀O
3	(R)-(+)-1-Phenylethanol	1517-69-7	C₈H₁₀O
4	N-((R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-propanamide	1005450-55-4	C₂₂H₂₀F₃NO
5	(R)-(+)-1-(1-Naphthyl)ethylamine	3886-70-2	C₁₂H₁₃N
6	(R)-Styrene Oxide	20780-53-4	C₈H₈O
7	(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride	521284-21-9	C₁₆H₁₈N₂O₃^.HCl
8	(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol	133775-25-4	C₁₂H₁₃F₂N₃O₂
9	1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole	127000-90-2	C₁₂H₁₁F₂N₃O
10	4-Methylidenepiperidine, Hydrochloride	144230-50-2	C₆H₁₂ClN
11	2-(2-Amino-5-bromobenzoyl)pyridine	1563-56-0	C₁₂H₉BrN₂O
12	Fmoc-L-glutamicacidgamma-methylester	145038-50-2	C₂₁H₂₁NO₆
13	Dimorpholinophosphinyl Chloride	7264-90-6	C₈H₁₆ClN₂O₃P
14	N-Tert-butyl-1H-indazole-7-carboxamide	1476776-76-7	C₁₂H₁₅N₃O
15	1H-Indazole-7-carboxylic Acid	677304-69-7	C₈H₆N₂O₂
16	[1,2,4]Triazolo[1,5-a]pyridin-7-ol	1033810-70-6	C₆H₅N₃O
17	3-Fluoro-5-hydroxybenzonitrile	473923-95-4	C₇H₄FNO
18	6,6-Dimethyl-3-azabicyclo[3.1.0]hexane	943516-54-9	C₇H₁₃N
19	7,8,9,10-Tetrahydro-8-(trifluoroacetyl)-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine	230615-70-0	C₁₅H₁₂F₃N₃O
20	4-Benzyl-2-hydroxy-morpholin-3-one	287930-73-8	C₁₁H₁₃NO₃
21	(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol	127852-28-2	C₁₀H₈F₆O
22	(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one	287930-75-0	C₂₁H₁₉F₆NO₃
23	(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate	200000-59-5	C₂₇H₂₆F₇NO₅S
24	N-Methylcarbonyl-2-chloroacetamidrazone	155742-64-6	C₄H₈ClN₃O₂
25	5-Chloromethyl-2,4-dithydro-[1,2,4]triazol-3-one	252742-72-6	C₃H₄ClN₃O
26	Tetrabenzyl Pyrophosphate	990-91-0	C₂₈H₂₈O₇P₂
27	(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile	207557-35-5	C₇H₉ClN₂O
28	3-Amino-1-hydroxyadamantane	702-82-9	C₁₀H₁₇NO
29	1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA)	60239-18-1	C₁₆H₂₈N₄O₈
30	Imidazole-1-yl-acetonitrile	98873-55-3	C₅H₅N₃
31	(S)-2-Chloro-1-(2,4-dichlorophenyl)ethanol	126534-31-4	C₈H₇Cl₃O
32	N-(2-Pyrazinylcarbonyl)-L-phenylalanine	114457-94-2	C₁₄H₁₃N₃O₃
33	2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione	446292-08-6	C₂₂H₁₉N₃O₆
34	2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)-phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione	446292-07-5	C₂₁H₂₁N₃O₅
35	(S)-2-Amino-5-methoxytetralin (S)-mandelate	439133-67-2	C₁₉H₂₃NO₄
36	1-Bromo-2,3-epoxypropane	3132-64-7	C₃H₅BrO
37	Glyoxal Dimethyl Acetal	51673-84-8	C₄H₈O₃
38	4-Bromo-2-fluorobiphenyl	41604-19-7	C₁₂H₈BrF
39	(S)-Flurbiprofen	51543-39-6	C₁₅H₁₃FO₂
40	3-Acetylaminopyrazole	3553-12-6	C₅H₇N₃O
41	Ethyl (2E)-3-(2-chlorophenoxy)but-2-enoate	1191997-59-7	C₁₂H₁₃ClO₃
42	2'-Fluoro-1,1':4',1''-terphenyl	113770-42-6	C₁₈H₁₃F
43	3-Methoxyperfluoro(2-methylpentane)	132182-92-4	C₇H₃F₁₃O
44	(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol	225920-05-8	C₁₀H₈OF₆
45	(1S,2S,3R,5S)-(+)-2,3-Pinanediol	18680-27-8	C₁₀H₁₈O₂
46	(S)-(-)-Styrene Oxide	20780-54-5	C₈H₈O
47	(R)-1-(4-Bromophenyl)ethanol	76155-78-7	C₈H₉BrO
48	(S)-1-(4-Bromophenyl)ethanol	100760-04-1	C₈H₉BrO
49	(R)-2-(4-Chlorophenyl)oxirane	21019-51-2	C₈H₇ClO
50	(S)-2-(4-Chlorophenyl)oxirane	97466-49-4	C₈H₇ClO
51	(R)-2-(1-Hydroxyethyl)pyridine	27911-63-3	C₇H₉NO
52	(S)-2-(1-Hydroxyethyl)pyridine	59042-90-9	C₇H₉NO
53	(R)-4-(1-Hydroxyethyl)pyridine	27854-88-2	C₇H₉NO
54	(S)-4-(1-Hydroxyethyl)pyridine	54656-96-1	C₇H₉NO
55	(R)-(3-Chlorophenyl)oxirane	62600-71-9	C₈H₇ClO
56	(R)-(4-Fluorophenyl)oxirane	134356-73-3	C₈H₇FO
57	(R)-(+)-1-(1-Naphthyl)ethanol	42177-25-3	C₁₂H₁₂O
58	(R)-(+)-1-(1-Naphthyl)ethanol	15914-84-8	C₁₂H₁₂O
59	Methylindole	603-76-9	C₉H₉N

Scan the QR code to read on your phone



Confirm

About Us

R&D and Innovation

Products

Innovation

Sustainable

News Center

Join Us

VIWIT 沪ICP备12014533号-2 Terms of Use

中文